why Baxter International Inc. [BAX] is a Good Choice for Investors After New Price Target of $59.16

Baxter International Inc. [NYSE: BAX] loss -7.74% or -3.75 points to close at $44.70 with a heavy trading volume of 13894837 shares. The company report on January 6, 2023 that Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Planning to spin off the Renal Care and Acute Therapies global business units into an independent, publicly traded company in the next 12-18 months.

Simplifying operating model and manufacturing footprint to drive strategic clarity, improve operational efficiencies and accelerate future growth.

It opened the trading session at $47.60, the shares rose to $47.95 and dropped to $44.47, the range by which the price of stock traded the whole day. The daily chart for BAX points out that the company has recorded -30.71% loss over the past six months. However, it is still 6.6% lower than its most recent low trading price.

If we look at the average trading volume of 4.69M shares, BAX reached to a volume of 13894837 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Baxter International Inc. [BAX]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $59.16 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on January 06, 2023. The new note on the price target was released on January 05, 2023, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another drop from $66 to $55, while BofA Securities kept a Neutral rating on BAX stock. On December 19, 2022, analysts decreased their price target for BAX shares from 68 to 55.

The Average True Range (ATR) for Baxter International Inc. is set at 1.71, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 1.66. The Price to Book ratio for the last quarter was 4.07, with the Price to Cash per share for the same quarter was set at 2.93. Price to Free Cash Flow for BAX in the course of the last twelve months was 132.88 with Quick ratio for the last quarter at 1.40.

Trading performance analysis for BAX stock

Baxter International Inc. [BAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.30. With this latest performance, BAX shares dropped by -14.61% in over the last four-week period, additionally sinking by -30.71% over the last 6 months – not to mention a drop of -48.49% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 26.96, with the RSI for the last a single of trading hit 21.44, and the three-weeks RSI is set at 31.23 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 52.51, while it was recorded at 49.82 for the last single week of trading, and 62.27 for the last 200 days.

Baxter International Inc. [BAX]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Baxter International Inc. [BAX] shares currently have an operating margin of +16.29 and a Gross Margin at +40.83. Baxter International Inc.’s Net Margin is presently recorded at +10.04.

Return on Equity for this stock inclined to 14.45, with Return on Assets sitting at 4.80.

Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.10.

Baxter International Inc. [BAX]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 4.14%.

An analysis of insider ownership at Baxter International Inc. [BAX]

There are presently around $19,233 million, or 89.50% of BAX stock, in the hands of institutional investors. The top three institutional holders of BAX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 58,992,617, which is approximately -4.677% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 43,399,216 shares of the stock with an approximate value of $1.94 billion in BAX stocks shares; and VANGUARD GROUP INC, currently with $1.84 billion in BAX stock with ownership of nearly 1.074% of the company’s market capitalization.

Positions in Baxter International Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 411 institutional holders increased their position in Baxter International Inc. [NYSE:BAX] by around 39,362,842 shares. Additionally, 521 investors decreased positions by around 34,862,407 shares, while 208 investors held positions by with 356,048,369 shares. The mentioned changes placed institutional holdings at 430,273,618 shares, according to the latest SEC report filing. BAX stock had 78 new institutional investments in for a total of 6,152,586 shares, while 135 institutional investors sold positions of 7,167,566 shares during the same period.


Please enter your comment!
Please enter your name here